Interestingly, this impairment occurred in the presence of basal IGF-I levels significantly lower than in simple obesity and not responsive to the short-term administration of a very low recombinant human GH dose. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.